These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1850057)

  • 21. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Systemic lupus erythematosus, the significance of immunologic tests].
    Michelsen B
    Z Hautkr; 1986 May; 61(10):667-70. PubMed ID: 2424185
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antiendothelial antibodies in systemic lupus erythematosus in men: the connection with kidney involvement and the antiphospholipid syndrome].
    Nasonov EL; Alekberova ZS; Salozhin KV; Kliukvina NG; Aleksandrova EN; Baranov AA; Le Tonqueze M; Youinou P
    Ter Arkh; 1996; 68(6):46-9. PubMed ID: 8771685
    [No Abstract]   [Full Text] [Related]  

  • 24. TG or not TG: IgG-anti-tissue transglutaminase in systemic lupus erythematosus: new role for an old enzyme.
    Tanay A; Brickman CM; Gas S; Misgav N; Frayman A; Lehman D
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):878-9. PubMed ID: 12455168
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibodies to dsDNA in drug induced lupus erythematosus.
    Cohen MG
    J Rheumatol; 1994 Mar; 21(3):578-9. PubMed ID: 8006909
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on the activity of selected lysosomal exoglycosidases in patients with systemic lupus erythematosus.
    Olczyk K; Drózdz M; Kucharz E; Piwowarczyk B; Kardaszewicz E; Harbut-Gryłka A
    Med Interne; 1984; 22(3):221-5. PubMed ID: 6436958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
    Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug-induced lupus erythematosus syndrome. Pathogenesis and relation to systemic lupus erythematosus].
    Wollina U
    Z Gesamte Inn Med; 1984 Mar; 39(5):69-73. PubMed ID: 6719963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical significance of myeloperoxydase and proteinase 2 antibodies in patients with systemic lupus erythematosus].
    Borodin AG; Baranov AA; Shilkina NP; Nasonov EL; Bazhina OV
    Klin Med (Mosk); 1999; 77(9):24-8. PubMed ID: 10599220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Activities of some lysosomal enzymes of human white blood cells in rheumatoid arthritis, lupus erythematosus and ankylosing spondylitis].
    Fidelski R; Tchórzewski H; Niedworok J
    Acta Haematol Pol; 1971; 2(3):229-34. PubMed ID: 5161837
    [No Abstract]   [Full Text] [Related]  

  • 31. Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus.
    Hellmich B; Csernok E; Schatz H; Gross WL; Schnabel A
    Arthritis Rheum; 2002 Sep; 46(9):2384-91. PubMed ID: 12355486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antinuclear factors. Demonstration and clinico-diagnostic significance].
    Maas D
    Med Klin; 1969 Jul; 64(29):1302-7. PubMed ID: 4184549
    [No Abstract]   [Full Text] [Related]  

  • 34. Sulfasalazine induced lupus in rheumatoid arthritis.
    Caulier M; Dromer C; Andrieu V; Le Guennec P; Fournie B
    J Rheumatol; 1994 Apr; 21(4):750-1. PubMed ID: 7913504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Oxygen intermediates and lysosomal enzymes generated by stimulated neutrophils from the patients with systemic lupus erythematosus, Behçet's disease and other disease groups (author's transl)].
    Niwa Y; Ishimoto K; Miyake S; Tsutsui I; Tsutsui D; Yokoyama M
    Nihon Naika Gakkai Zasshi; 1981 Sep; 70(9):1236-48. PubMed ID: 7320606
    [No Abstract]   [Full Text] [Related]  

  • 36. Human lysosomal elastase. Catalytic and immunological properties.
    Starkey PM; Barrett AJ
    Biochem J; 1976 May; 155(2):265-71. PubMed ID: 938478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydralazine induced lupus and Sweet's syndrome. Report and review of the literature.
    Ramsey-Goldman R; Franz T; Solano FX; Medsger TA
    J Rheumatol; 1990 May; 17(5):682-4. PubMed ID: 2193156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of biological markers of activity of systemic lupus erythematosus with levels of anti-oxidized low-density lipoprotein antibodies.
    Gómez-Zumaquero JM; Tinahones FJ; De Ramón E; Camps M; Garrido L; Soriguer FJ
    Rheumatology (Oxford); 2004 Apr; 43(4):510-3. PubMed ID: 14872100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutrophil activation detected by increased neutrophil elastase activity in type 1 (insulin-dependent) diabetes mellitus.
    Collier A; Jackson M; Bell D; Patrick AW; Matthews DM; Young RJ; Clarke BF; Dawes J
    Diabetes Res; 1989 Mar; 10(3):135-8. PubMed ID: 2805587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of phagocytosis and lysosomal enzyme release from human leukocytes by serum from patients with systemic lupus erythematosus.
    Zurier RB
    Arthritis Rheum; 1976; 19(1):73-8. PubMed ID: 1252270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.